ОПАСНОСТЬ НЕРАВЕНСТВА [Dangerous Inequalities: World AIDS Day report 2022]
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID.
This graphic discusses the effects of the COVID-19 pandemic on the HIV response
This infographic discusses how girls and women make up more than half of the 37.7 million people living with HIV. Ending AIDS by 2030 requires that we address girls’ and women’s diverse roles by putting them at the centre of the response.
The purpose of this NIH Mentored Research Scientist Development Award (K01) is to provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as preclinical models.
The purpose of this funding opportunity announcement (FOA) is to support preclinical HIV/AIDS research using NHP models performed by Early Stage Investigators (ESIs) who are within 10 years of their terminal degree or completion of their residency training but who have at least two years of postdoctoral experience.
This research discusses how PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. Black and Hispanic people have higher rates of new HIV diagnoses than White non-Hispanic people in the US. We describe the inequitable use of PrEP by race within US regions from 2012-2021.